![Fergus Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 14 422 $ per 2026-05-31
Fergus Fleming is currently the Director & Chief Technology Officer at Renalytix Plc.
Previously, he worked as the Managing Director at Ff Consulting Ltd. from 2014 to 2018.
He also served as the Head-Business Development at Oncomark Ltd. from 2016 to 2018.
Mr. Fleming completed his undergraduate degree at the National University of Ireland Galway.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
RENALYTIX PLC 0,14 % | 2024-12-20 | 594 481 ( 0,14 % ) | 14 422 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| RENALYTIX PLC | Teknisk/Vetenskaplig/F&U Direktör | 2018-03-15 |
| Företag | Position | Slut |
|---|---|---|
Ff Consulting Ltd. | Verkställande Direktör | 2018-11-01 |
Oncomark Ltd.
 Oncomark Ltd. Medical SpecialtiesHealth Technology Operates as a diagnostics company that develops novel cancer biomarkers | Företagsledare/Principal | 2018-10-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 4 |
|---|---|
Oncomark Ltd.
Oncomark Ltd. Medical SpecialtiesHealth Technology Operates as a diagnostics company that develops novel cancer biomarkers | Health Technology |
National University of Ireland Galway
 National University of Ireland Galway Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Renalytix Plc
 Renalytix Plc Packaged SoftwareTechnology Services Provides artificial intelligence for kidney disease | Technology Services |
Ff Consulting Ltd. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
